Incyte (INCY) EPS (Diluted) (2010 - 2026)
Incyte (INCY) recorded EPS (Diluted) of $2.81 in Q2 2026, up 38.0% from $2.04 a year earlier and up 91.8% from the prior quarter.
Powered by 
Analysis
Incyte (INCY) EPS (Diluted) (2010 - 2026) Analysis & Trends
On a TTM basis, Incyte's EPS (Diluted) came in at $7.74 as of Jun 30, 2026, up 76.7% year-over-year; for FY2025, it was $6.41.
- Across earlier years, EPS (Diluted) came in at $0.15 in FY2024 (-94.1%), $2.65 in FY2023 (+73.9%), $1.52 in FY2022 (-64.4%) and $4.27 in FY2021.
- The Q2 2026 figure is the highest quarterly EPS (Diluted) in data going back to Q1 2010.
- On a year-over-year basis, EPS (Diluted) has increased for four consecutive quarters, with growth averaging 64.5% over the last seven quarters.
- Peak year-over-year performance for EPS (Diluted) in the last five years was growth of 675.6% in Q1 2024, against a decline of 95.0% in Q4 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.47 (Q1 2026), $1.49 (Q4 2025) and $2.11 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 2.27 |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.04 |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -0.54 |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 1.67 |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 1.85 |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 4.37 |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -8.44 |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -0.04 |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 4.31 |
| 10 | Incyte | 25.09 Bn | 10.02 Bn | 1.57 Bn | 2.81 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.81 |
| Mar 31, 2026 | 1.47 |
| Dec 31, 2025 | 1.49 |
| Sep 30, 2025 | 2.11 |
| Jun 30, 2025 | 2.04 |
| Mar 31, 2025 | 0.80 |
| Dec 31, 2024 | 0.96 |
| Sep 30, 2024 | 0.54 |
| Jun 30, 2024 | -2.04 |
| Mar 31, 2024 | 0.75 |
| Dec 31, 2023 | 0.89 |
| Sep 30, 2023 | 0.76 |
| Jun 30, 2023 | 0.90 |
| Mar 31, 2023 | 0.10 |
| Dec 31, 2022 | 0.13 |
| Sep 30, 2022 | 0.50 |
| Jun 30, 2022 | 0.72 |
| Mar 31, 2022 | 0.17 |
| Dec 31, 2021 | 2.54 |
| Sep 30, 2021 | 0.82 |
API Access
Incyte EPS (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=eps-diluted&ticker=INCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "eps-diluted", "ticker": "INCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=eps-diluted&ticker=INCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();